Effect of secretory DKK3 on circulating CD56bright natural killer cells in patients with liver cancer

被引：0
|
作者：
Liu, Da-Hua [1 ]
Wen, Gui-Min [2 ]
Song, Chang-Liang [3 ]
Xia, Pu [1 ,4 ]
机构：
[1] Jinzhou Med Univ, Biol Anthropol Inst, Coll Basic Med Sci, Jinzhou, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Coll Nursing, Dept Community Nursing, Jinzhou, Liaoning, Peoples R China
[3] Ctr Hosp Handan, Dept Radiotherapy, Handan, Hebei, Peoples R China
[4] Jinzhou Med Univ, Biol Anthropol Inst, Jinzhou 121000, Liaoning, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2023年 / 38卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Liver cancer; DKK3; NK cells; differentiation; cytotoxicity; NK CELLS; METHYLATION; EXPRESSION; MECHANISM; ALPHA;
D O I：
10.1177/03936155231169796
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Background Liver cancer seriously threatens human health. Natural killer (NK) cells are an important part of the innate immune system and have strong anti-tumor ability. Immunotherapy based on NK cells has become a hot topic in the treatment of liver cancer. Methods In this study, we checked the serum DKK3 (sDKK3) and circulating CD56(bright) NK cells using ELISA and flow cytometry, respectively, in the blood of liver cancer patients. The effect on recombinant human DKK3 (rhDKK3) on CD56(bright) NK cells was analyzed in vitro. Results We found low levels of sDKK3 in liver cancer patients and a negative correlation between sDKK3 and circulating CD56(bright) NK cells. In addition, we found that DKK3 induced the differentiation and improved the cytotoxicity of CD56(bright) NK cells for the first time. It could be used as an agonist for NK cell-based immunotherapy. Conclusions Improving the clinical efficacy of NK cells through DKK3 will become a new strategy for cancer immunotherapy.
引用
收藏
页码：99 / 104
页数：6
相关论文
共 50 条
  • [11] Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
    Saraste, M.
    Irjala, H.
    Airas, L.
    NEUROLOGICAL SCIENCES, 2007, 28 (03) : 121 - 126
  • [12] Mature Cytotoxic CD56bright/CD16+ Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma
    Messaoudene, Meriem
    Fregni, Giulia
    Fourmentraux-Neves, Emmanuelle
    Chanal, Johan
    Maubec, Eve
    Mazouz-Dorval, Sarra
    Couturaud, Benoit
    Girod, Angelique
    Sastre-Garau, Xavier
    Albert, Sebastien
    Guedon, Charles
    Deschamps, Lydia
    Mitilian, Delphine
    Cremer, Isabelle
    Jacquelot, Nicolas
    Rusakiewicz, Sylvie
    Zitvogel, Laurence
    Avril, Marie-Francoise
    Caignard, Anne
    CANCER RESEARCH, 2014, 74 (01) : 81 - 92
  • [13] Timed Sexual Intercourse Facilitates the Recruitment of Uterine CD56bright Natural Killer Cells in Women with Infertility
    Kimura, Hidetaka
    Fukui, Atsushi
    Fujii, Shunsaku
    Yamaguchi, Eiji
    Kasai, Goichiro
    Mizunuma, Hideki
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2009, 62 (02) : 118 - 124
  • [14] Abnormalities of quantities and functions of CD56bright natural killer cells in non-severe aplastic Anemia
    Li, Yang
    Ding, Shaoxue
    Liu, Chunyan
    Chen, Tong
    Liu, Hui
    Li, Lijuan
    Shao, Zonghong
    Fu, Rong
    HEMATOLOGY, 2019, 24 (01) : 405 - 412
  • [15] Circulating CD56bright NK cells inversely correlate with survival of melanoma patients
    de Jonge, Kaat
    Ebering, Anna
    Nassiri, Sina
    Maby-El Hajjami, Helene
    Ouertatani-Sakouhi, Hajer
    Baumgaertner, Petra
    Speiser, Daniel E.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [16] The involvement of circulating CD69+ CD56bright natural killer cells in weight loss before bariatric surgery: A retrospective cohort study
    Chikuie, Emi
    Saeki, Yoshihiro
    Tanabe, Kazuaki
    Ota, Hiroshi
    Tanaka, Yuka
    Ohdan, Hideki
    MEDICINE, 2023, 102 (41) : E34999
  • [17] Circulating growth/differentiation factor 15 is associated with human CD56bright natural killer cell dysfunction and nosocomial infection in severe systemic inflammation
    Kleinertz, Holger
    Hepner-Schefczyk, Monika
    Ehnert, Sabrina
    Claus, Maren
    Halbgebauer, Rebecca
    Boller, Lea
    Huber-Lang, Markus
    Cinelli, Paolo
    Kirschning, Carsten
    Flohe, Sascha
    Sander, Andre
    Waydhas, Christian
    Vonderhagen, Sonja
    Jaeger, Marcus
    Dudda, Marcel
    Watzl, Carsten
    Flohe, Stefanie B.
    EBIOMEDICINE, 2019, 43 : 380 - 391
  • [18] Single-cell profiling aligns CD56bright and cytomegalovirus-induced adaptive natural killer cells to a naïve-memory relationship
    Panjwani, M. Kazim
    Grassmann, Simon
    Sottile, Rosa
    Le Luduec, Jean-Benoit
    Kontopoulos, Theodota
    van der Ploeg, Kattria
    Sun, Joseph C.
    Hsu, Katharine C.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [19] Human Natural Killer Cell Maturation Defect Supports In Vivo CD56bright to CD56dim Lineage Development
    Ines Domaica, Carolina
    Beatriz Fuertes, Mercedes
    Uriarte, Ignacio
    Victoria Girart, Maria
    Sardanons, Jessica
    Ileana Comas, Dorina
    Di Giovanni, Daniela
    Isabel Gaillard, Maria
    Bezrodnik, Liliana
    Walter Zwirner, Norberto
    PLOS ONE, 2012, 7 (12):
  • [20] Increased Frequency of CD39+ CD56bright Natural Killer Cells in HIV-1 Infection Correlates With Immune Activation and Disease Progression
    Dierks, Patrick
    Wroblewski, Raluca
    Eberhard, Johanna M.
    Martrus, Gloria
    Degen, Olaf
    Hertling, Sandra
    Schmiedel, Stefan
    Lunemann, Sebastian
    Huefner, Anja
    Lohse, Ansgar W.
    Altfeld, Marcus
    van Lunzen, Jan
    zur Wiesch, Julian Schulze
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 (04) : 467 - 472
12345